Reza Khosravan is the Executive Director of Clinical Pharmacology & Pharmacometrics at Exelixis, focused on developing new cancer therapies. Holding a PhD from the University of Alberta, his extensive career includes senior leadership roles at Arcus Biosciences and Pfizer, specializing in clinical study design, drug development, and pharmacometrics.
He is a widely published scientist, having co-authored numerous research papers and articles in the field of clinical pharmacology, with a focus on drug-drug interactions and pharmacokinetics.
Reza Khosravan
Executive Director at Exelixis
San Diego, California, United States
Overview
Topics They Care About
New Cancer Therapies
Expressed his commitment to being part of a team dedicated to bringing new cancer therapies to patients upon joining Exelixis.
Model Informed Drug Development
This advanced skill (MIDD) is a core component of his expertise, highlighted across his senior roles at Pfizer, Arcus, and TAP Pharmaceuticals.
Clinical Pharmacology
His entire career, from his PhD to his current executive role, is centered on this discipline, evidenced by numerous scientific publications.
Media Appearances
Reza has no verified media appearances
Work History
6-2025
Executive Director at Exelixis
4-2024 - 5-2025
Executive Director at Arcus Biosciences
6-2006 - 2-2024
Senior Director at Pfizer Inc
11-1999 - 5-2006
Senior Research Investigator at TAP Pharmaceutical Products Inc
Education
9-1993 - 10-1999
Doctor of Philosophy - PhD from University of Alberta
9-1989 - 8-1993
Bachelor of Pharmacy - BPharm from University of Alberta
More Information
Social Presence :
Prographics :
Exp : 25
Location : San Diego, California, United States
Job Level : Senior
Designation : Executive Director at Exelixis
